ISSN: 2161-0460

Journal of Alzheimers Disease & Parkinsonism
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Short Communication

Blood Derived Induced Pluripotent Stem Cells (iPSCs): Benefits, Challenges and the Road Ahead

Jimmy El Hokayem1, Holly N Cukier1,2# and Derek M Dykxhoorn1,3*

1John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, USA

2Department of Neurology, University of Miami Miller School of Medicine, Miami, USA

3John T. Macdonald Foundation Department of Human Genetics, University of Miami Miller School of Medicine, Miami, USA

4#Equal Contribution

*Corresponding Author:
Derek M. Dykxhoorn
John P. Hussman Institute for Human Genomics
University of Miami Miller School of Medicine
1501 NW 10th Ave, Biomedical Research Building
Room 509, Miami, USA
Tel: (305) 243-7596
E-mail: DDykxhoorn@med.miami.edu

Received date October 13, 2016; Accepted date October 18, 2016; Published date October 25, 2016

Citation: Hokayem JEl, Cukier HN, Dykxhoorn DM (2016) Blood Derived Induced Pluripotent Stem Cells (iPSCs): Benefits, Challenges and the Road Ahead. J Alzheimers Dis Parkinsonism 6:275. doi: 10.4172/2161-0460.1000275

Copyright: © 2016 Hokayem JEl, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.



Abstract

Since the creation of induced Pluripotent Stem Cells (iPSCs) ten years ago, hundreds of publications have demonstrated their considerable impact on disease modeling and therapy. In this commentary, we will summarize key milestones, benefits and challenges in the iPSC field. Furthermore, we will highlight blood as an effective and easily accessible source for patient-specific iPSCs derivation in the context of work done in our laboratory and others.

https://bahigox.fun/ https://bahisjet.fun/ https://bahsegel.fun/ https://betboo.fun/ https://betdoksan.xyz/ https://betebetgiris.xyz/ https://betexper.fun/ https://betgram.fun/ https://betkanyon.fun/ https://betkolik.fun/
Top